𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of autologous pregnancy plasma to treat a flare of juvenile rheumatoid arthritis: Case report and literature review

✍ Scribed by Daniel J. Wallace; Dennis Goldfinger; James R. Klinenberg


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
255 KB
Volume
3
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis


A patient with juvenile rheumatoid arthritis whose disease was in remission during pregnancy underwent thirdtrimester plasmaphereses. The stored plasma was returned to her 1 year postpartum, when the disease flared. without beneficial results. The literature on the use of blood products in rheumatoid arthritis and pregnancy is rcviewed.


πŸ“œ SIMILAR VOLUMES


Hydroxyurea use during pregnancy: A case
✍ Diav-Citrin, Orna; Hunnisett, Laura; Sher, Graham D.; Koren, Gideon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 19 KB πŸ‘ 2 views

A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-oclusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malfor

Rituximab as an adjunct to plasma exchan
✍ Sushama Jasti; Thomas Coyle; Teresa Gentile; Lawrence Rosales; Bernard Poiesz πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 1 views

## Abstract Idiopathic thrombotic thrombocytopenic purpura (TTP) is caused by the production of autoantibodies against the Von Willebrand factor cleaving enzyme. This provides a rationale for the use of rituximab in this disease. We report a retrospective review of 12 patients treated with rituxima

Use of plasma exchange in patients with
✍ Elizabeth A. Jaben; A. Sergio Torloni; Rajiv K. Pruthi; Jeffrey L. Winters πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 1 views

## Abstract Heparin‐induced thrombocytopenia (HIT), which is characterized by thrombocytopenia and potentially serious thromboses, may develop in patients exposed to heparin anticoagulation. HIT is caused by antibodies to the heparin/platelet factor 4 (PF4) complex. Management of HIT involves disco